Leukemia Program
855-776-4224
Call the Mass General Brigham Cancer Institute at 855-776-4224
Internationally recognized leukemia care
Bone marrow cancers and acute leukemias occur when the bone marrow makes too many or malignant, abnormal blood cells. The disease can be fast or slow-growing and affect all age groups, requiring specialized care for each patient’s unique needs.
The Mass General Brigham Cancer Institute is internationally recognized for its expertise in diagnosing and managing all types of bone marrow cancer. We offer effective and innovative therapeutic options, including targeted agents, novel therapies, bone marrow transplants, and other treatments to help you return to the life that matters most to you.
Our approach to leukemia care
Your care team includes hematopathologists who are known around the world for their expertise in diagnosing all types of leukemia. We use the latest diagnostic tools, including:
- Advanced microscopy
- Chromosomal microarray analysis
- Flow cytometry
- Fluorescence in situ hybridization (FISH)
- Genome mapping
- Karyotyping
- Histochemical analysis
- Rapid molecular and genetic testing
Our team features blood cancer doctors who focus on specific types of leukemias, ensuring you receive the most effective care plan. You have access to all medications used to treat acute leukemia and other bone marrow cancers, including:
- Chemotherapy
- Targeted therapies for subtypes of disease
- Immunotherapy, including CAR T-cell therapy
For some people with leukemia, a bone marrow transplant may be recommended. Through our Bone Marrow Transplant Program, we provide advanced transplant care and evidence-based therapies to help prevent and manage complications that can occur after transplant, including graft-versus-host disease (GVHD).
Transplants we offer for leukemia include:
- Allogeneic transplant with a matched, related donor
- Allogeneic transplant with a mismatched or unrelated donor
- Umbilical cord blood transfusions
Specialized treatments for all types of leukemia
- Myeloproliferative Neoplasms
- Acute Myeloid Leukemia (AML)
- Chronic Myeloid Leukemia (CML)
- Polycythemia Vera
- CAR T-Cell Therapy for Lymphoma
- Chemotherapy for Lung Cancer
- Bone Marrow Transplant
- Peripheral Blood Stem Cell Transplant (PBSCT) for Cancer
- Acute Promyelocytic Leukemia (APL) Treatment
- Targeted Therapy for Cancer
- Immunotherapy for Cancer Monoclonal Antibodies (mAbs)
- Bone Marrow Aspiration and Biopsy
- IV Chemotherapy
- Oral Medications to Treat Cancer
Cancer clinical trials and research
Explore our cancer research
Learn how cancer research informs patient care
Search clinical trials
Patient resources and support
View all patient resources
Contact the Cancer Institute
855-776-4224
Call the Mass General Brigham Cancer Institute at 855-776-4224
International Patient Services
Contact International Patient Services